Mechanistically, IP-DNQ exterminates NQO1-positive cancer cells by generating excessive reactive oxygen species (ROS), thereby inducing DNA damage, PARP1 hyperactivation, and catastrophic energy loss. The gene discussed is PARP1; the disease is cancer.